Bausch Health Companies | Les Charges D'Exploitation



Operating Expenses Changement Date
Amgen USD 6.52B 337M 2025-06
ANI Pharmaceuticals USD 196.2M 25.27M 2025-06
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bausch Health Companies USD 2.07B 90M 2025-06
Biogen USD 1.79B 326.1M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Danaher USD 5.18B 718M 2025-06
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Novo Nordisk 42.77B 3.48B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Perrigo USD 1B 36.2M 2025-06
Prestige Brands USD 177.77M 30.32M 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06
Zoetis USD 1.44B 35M 2025-06


Bausch Health Companies Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.